The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic review, pairwise, and network meta-analysis.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Conflict of interestThe authors declare no conflict of interest. Conflict of interest The authors declare no conflict of interest."

"Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB)."

"This systematic review and meta-analysis was thoroughly conducted in accordance with the Preferred Reporting Items for Systematic Reviews, Meta-analysis, and Network Meta-Analyses (PRISMA [] and PRISMA NMA []) and the Cochrane Handbook of Systematic reviews and meta-analysis []. Moreover, this review’s protocol was prospectively published and registered in PROSPERO with ID: CRD42022358082. The thorough PRISMA checklist is in Table ."